Schedule 13G ownership disclosure

SILEXION THERAPEUTICS CORP

Ordinary Shares, par value $0.0001 per share · CUSIP: G1281K122

Event date: 2025-03-31

Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.

Filing-level shares
Unavailable
Percent of class
Unavailable
  • THE GOLDMAN SACHS GROUP, INC.

    Shares: 211,945.00 · Class: 2.4%

  • GOLDMAN SACHS & CO. LLC

    Shares: 211,945.00 · Class: 2.4%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000769993-25-000290
Form type
SCHEDULE 13G/A
Filer
GOLDMAN SACHS GROUP INC
CIK
CIK 886982
Filed
May 13, 2025
Reporting period
Mar 31, 2025
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub